Yes, I should have. We closed today at 13.77.
Moronic target of $12, when he is predicting profitably, increasing scrips etc
What you did not mention is that he still maintains a $12 target.
Sentiment: Strong Sell
These are games that these analysts play......
Wedbush's Gregory Wade reverses course and upgrades Ironwood Pharmaceuticals (IRWD) to Neutral from Underperform — he downgraded the shares a little over a month ago after asking some pointed questions regarding R&D expenditures on the CC. Wade now says higher W/W script growth should lead to greater net sales of Linzess (IRWD disappointed with Linzess sales in Q1) which ultimately means a lower balance sheet gap to profitability ($150M versus $200M). Wade also says the company shouldn't need any more equity financing. Shares +1% premarket.
I missed it, but why did they need the money? They have a product that's now on the market.
To answer your question- it wasn't too hard when the price was 14 to make them think it was a deal.
Btw when did you cover your short position?
how does the company sell 10,500,000 shares of common stock to the public for $13 a share when the stock is trading under 13? I realize the general public isn't very smart but this I do not understand. Maybe I'm the dumb one? Someone please advise me. Thanks in advance
My spouse and I preferred to present this link with every body. This website has a newsletter with detailed info of hot small-cap stocks.
[Remove Dot and Use . ]
Agree. Read the Seeking alfa article on Synergy yesterday . The article in fact is more positive on Linzess and compares its growth to Zelnorm . Expects Linzess to be a blockbuster.Synergy drug is 3 years away and until then Linzess should have a great run.